A Safety and Efficacy Assessment of Resolvine for Treatment of Vitreomacular Attachment

NCT01966328 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Vitreomacular Attachment
Vitreomacular Traction
Vitreomacular Adhesion

Interventions

DRUG: 36% Resolvine Intravitreal Injection
DRUG: 9% Resolvine Intravitreal Injection

Sponsor

Jeffrey S Heier

Collaborators

[object Object]